Prelude Therapeutics Inc. (PRLD)
Market Closed
13 Jun, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
0. 96
-0.08
-7.69%
$
58.72M Market Cap
- P/E Ratio
0% Div Yield
71,200 Volume
-2 Eps
$ 1.04
Previous Close Day Range
0.92 1.02
Year Range
0.61 6.8
Want to track PRLD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| PRLD Prelude Therapeutics Inc. 5 May 2025 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 13 Feb 2025 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 30 Oct 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 12 Aug 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 2 Aug 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 1 Aug 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 14 Jun 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 6 Jun 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 14 May 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 15 Feb 2024 | | - Cons. EPS | - EPS |
| PRLD Prelude Therapeutics Inc. 1 Nov 2023 | | - Cons. EPS | - EPS |
2025 © Marketlog. All Rights Reserved.
